MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Pathophysiology"

  • 2024 International Congress

    Nocturnal Blood Pressure, Non-Dipping, Psychosis And Non-Motor Symptoms In Early Stages Of Huntington’s Disease Patients

    R. Singh, V. Sharma (New Delhi, India)

    Objective: The aim of this study was to determine the relationship between 24 h ambulatory blood pressure measurements (ABPM), i.e., absence or presence of nocturnal…
  • 2024 International Congress

    Exploring Correlations between Mutant Huntingtin, NfL, and MRI in Huntington’s Disease: A Multimodal Analysis

    J. Pérez, S. Horta, G. Saura, A. Barba, A. Davi, A. Vázquez, E. Rivas, A. Campolongo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: This study aims to investigate correlations between mHtt and NfL levels and MRI findings in individuals at different stages of HD, including presymptomatic and…
  • 2023 International Congress

    Longitudinal imaging of regional volumes, presynaptic terminals and glucose metabolism in brains of people with early Huntington’s disease

    A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To compare the sensitivity of 11C‑UCB‑J PET, 18F-FDG PET and volumetric MRI for detection of longitudinal brain changes in early Huntington’s Disease (HD). Background:…
  • 2023 International Congress

    Levodopa-induced dyskinesia and Huntington’s chorea: link to current motor control theories

    JF. Daneault, Y. Liu, J. Miranda, C. Duval, M. Chen, S. Lee (Newark, USA)

    Objective: Determine if there is a motor control hypothesis that could explain movement kinematics of Huntington’s disease (HD) chorea and Parkinson’s disease (PD) levodopa-induced dyskinesia…
  • 2023 International Congress

    Pallidal activity as a driving force of choreic movements

    T. Hashimoto, T. Goto, K. Yoshida, L. Johnson, C. Hendrix, J. Vitek (Matsumoto, Japan)

    Objective: To investigate the mechanisms of neuronal discharges of the globus pallidus which drive choreic movements. Background: Synchronized bursts and the low discharge rates of…
  • 2023 International Congress

    Effects of cerebellar cTBS on motor symptoms in Huntington’s disease: a feasibility and pilot study

    JF. Martin Rodriguez, M. Gomez Crespo, FJ. Gómez Campos, AM. Castellano-Gerrero, V. Villarreal, FJ. Palomar Simón, P. Porcacchia, F. Carrillo, S. Jesús, P. Mir (Sevilla, Spain)

    Objective: To evaluate the feasibility and preliminary clinical effects of a single session of cerebellar cTBS in patients with Huntington's disease (HD) with mild-moderate motor…
  • 2023 International Congress

    Localisation of distinct brain networks in premanifest and manifest Huntington’s disease

    E. Younger, E. Ellis, J. Joutsa, D. Corp (Burwood, Australia)

    Objective: To map the brain networks underlying Huntington’s Disease (HD), testing whether there are distinct networks involved in premanifest and manifest disease stages. Background: HD…
  • 2023 International Congress

    Autoimmune Chorea. Therapy with Monoclonal Antibodies: Experimental and Clinical Approach

    D. Labunskiy, S. Kiryukhina, D. Kuzmin, V. Podsevatkin (Saransk, Russian Federation)

    Objective: Autoimmune chorea (AICh) resulting from the appearance of paraneoplastic antibodies in response to development of malignant tumors of various localization. Sydenham's rheumatic chorea, described…
  • MDS Virtual Congress 2021

    Diabetes Mellitus in Huntington’s disease. The Argentinean perspective

    N. Gonzalez Rojas, M. Cesarini, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: to compare the prevalence of diabetes mellitus (DM) in a self-reported series of local Huntington disease (HD) participants in the ENROLL-HD registry with the…
  • MDS Virtual Congress 2021

    Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles

    E. Mcdonnell, Y. Wang, K. Marder (New York, USA)

    Objective: To estimate risk of Huntington’s disease (HD) over time in patients with reduced penetrance (RP) alleles (36-39 CAG repeats) overall, by individual repeat length,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley